A protein that accumulates in the skeletal muscle of people with type 2 diabetes could offer a direction for future treatment research, according to a study announced on Monday by the University of Oklahoma. The work concerns Miro1 and the muscle’s response to insulin, not a new medicine already available to patients. The university said The post Miro1 protein offers a possible new target in type 2 diabetes research appeared first on PakTribune.



